MAN-CHIU POON, M.D.; JOHN R. DURANT, M.D.; MICHAEL J. NORGARD, M.D.; VIVIEN Y-H. CHANG-POON, M.D.
Inflammatory fibrous histiocytoma is a recently recognized variant of malignant fibrous histiocytoma. Patients managed with surgical excision or radiation therapy usually have had multiple recurrences, often with metastases. The disease is insidious but ultimately fatal. Four consecutive patients were treated with inflammatory fibrous histiocytoma with alkylating agents with or without anthracyclines and produced prolonged and sustained remissions. Inflammatory fibrous histiocytoma may be another highly chemotherapeutically responsive tumor that deserves active case identification for aggressive curative therapy.
POON M, DURANT JR, NORGARD MJ, et al. Inflammatory Fibrous Histiocytoma: An Important Variant of Malignant Fibrous Histiocytoma Highly Responsive to Chemotherapy. Ann Intern Med. 1982;97:858–863. doi: https://doi.org/10.7326/0003-4819-97-6-858
Download citation file:
Published: Ann Intern Med. 1982;97(6):858-863.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use